FRIDAY, Oct. 10, 2025 (HealthDay News) — Patients experiencing a sickle cell crisis can wind up waiting hours in agony if inappropriately triaged by ER staff, a new study says. Patients misplaced in a less severe pain category waited nearly three times as long for their first dose of painContinue Reading
FRIDAY, Oct. 10, 2025 (HealthDay News) — Low-dose IV infusions of ketamine are safe and effective in treating chronic pain, a new study says. Ketamine infusions as part of comprehensive clinical pain care helped as many as 46% of patients improve their physical function, sleep quality and pain management, researchersContinue Reading
THURSDAY, Oct. 9, 2025 (HealthDay News) — A widely prescribed opioid painkiller is not all it’s cracked up to be, a new evidence review has concluded. The opioid painkiller tramadol does little to reduce moderate to severe pain, according to results published Oct. 7 in the journal BMJ Evidence BasedContinue Reading
WEDNESDAY, Sept. 24, 2025 (HealthDay News) — The fight against America’s opioid crisis does not appear to have cost cancer patients the painkillers they need, a new study says. There was a decline in opioid prescriptions among cancer patients between 2016 and 2020, researchers reported in the October issue ofContinue Reading
SUNDAY, Sept. 14, 2025 (HealthDay News) — Everyone gets headaches, but not all headaches are the same. For some, they’re a quick inconvenience. For others, they can be intense, long-lasting and even disabling, disrupting daily life for days or weeks. Experts say finding the right treatment depends on identifying theContinue Reading
New guidance aims to increase nonopioid choices for chronic pain while combating misuseContinue Reading
FRIDAY, Aug. 29, 2025 (HealthDay News) — Common over-the counter painkillers might be quietly fueling antibiotic resistance, a new study warns. Ibuprofen and acetaminophen appear to enhance mutations in E. coli, making the common bacteria more resistant to the broad-spectrum antibiotic ciprofloxacin, researchers reported in the journal npj Antimicrobials andContinue Reading
Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in more than 15 yearsContinue Reading
Drugmaker aims to pursue other applications in mental health, neurological, and pain disordersContinue Reading
WEDNESDAY, July 16, 2025 (HealthDay News) — Folks seeking relief from low back pain in an ER aren’t likely to leave with a prescription for opioids. The rate of ER opioid prescriptions for back pain fell by more than half between 2016 and 2022, researchers reported July 12 in theContinue Reading